Thymoma and thymic carcinoma: An update of the WHO classification 2004

Surgery Today

Volumn 35, Issue 10, 2005, Pages 805-811

  Ströbel, Philipp ^a   Marx, Alexander ^a   Zettl, Andreas ^a   Müller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Genetics; Thymic carcinoma; Thymoma; Thymus

Indexed keywords

CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; IMATINIB; OCTREOTIDE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR;

BIPHASIC METAPLASTIC THYMOMA; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 15; CLINICAL TRIAL; DISEASE CLASSIFICATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; LIVER CARCINOMA; MICRONODULAR THYMOMA; NEUROENDOCRINE TUMOR; PLEURA METASTASIS; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; THYMOMA; THYMOMA TYPE A; THYMOMA TYPE AB; THYMOMA TYPE B; THYMOMA TYPE B 1; THYMOMA TYPE B 2; THYMOMA TYPE B 3; THYMUS CANCER; THYMUS CARCINOMA; TREATMENT FAILURE; TUMOR DIFFERENTIATION; WORLD HEALTH ORGANIZATION;

EID: 25444476048     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-005-3047-y     Document Type: Review

References (79)

1. J Rosai L Sobin 1999 Histological typing of tumours of the thymus World Health Organization. International histological classification of tumours Springer Berlin Heidelberg 1 16
2. M Okumura M Ohta H Tateyama K Nakagawa A Matsumura H Maeda 2002 The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients Cancer 94 624 32
3. G Chen A Marx C Wen-Hu J Yong B Puppe P Strobel 2002 New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China Cancer 95 420 9
4. K Kondo K Yoshizawa M Tsuyuguchi S Kimura M Sumitomo J Morita 2004 WHO histologic classification is a prognostic indicator in thymoma Ann Thorac Surg 77 1183 8
5. P Strobel A Bauer B Puppe T Kraushaar A Krein K Toyka 2004 Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis J Clin Oncol 22 1501 9
6. N de Saint Aubain Somerhausen C Richard D Priollet D Dequanter 2004 Ectopic hamartomatous thymoma: a case report and review of the literature Ann Pathol 24 176 8
7. JB Cohen M Troxell CS Kong IR McDougall 2003 Ectopic intrathyroidal thymoma: a case report and review Thyroid 13 305 8
8. A Marx P Strobel A Zettl JKC Chan NL Harris TT Kuo 2004 Thymomas WD Travis E Brambilla HK Müller-Hermelink CC Harris World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, thymus and heart. Vol. 7 IARC Press Lyon 152 3
9. M Inoue P Starostik A Zettl P Strobel S Schwarz F Scaravilli 2003 Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas Cancer Res 63 3708 15
10. G Qiu Z Xu D Huang L Gong C Li X Sun 2003 [Cloning and characterization of MTLC, a novel gene in 6q25] Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20 94 7
11. CY Chiu S Leng KA Martin E Kim S Gorman DM Duhl 1999 Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1 Genomics 61 66 73
12. G Giglia-Mari F Coin JA Ranish D Hoogstraten A Theil N Wijgers 2004 A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A Nat Genet 36 714 9
13. M Inoue A Marx A Zettl P Strobel HK Muller-Hermelink P Starostik 2002 Chromosome 6 suffers frequent and multiple aberrations in thymoma Am J Pathol 161 1507 13
14. R Zhou A Zettl P Strobel K Wagner HK Muller-Hermelink S Zhang 2001 Thymic epithelial tumors can develop along two different pathogenetic pathways Am J Pathol 159 1853 60
15. P Dal Cin C De Wolf-Peeters MS Aly G Deneffe W Van Mieghem H Van Den Berghe 1993 Ring chromosome 6 as the only change in a thymoma Genes Chromosomes Cancer 6 243 4
16. SG Goh LC Lau C Sivaswaren KL Chuah PH Tan D Lai 2001 Pseudodicentric (16;12)(q11;p11.2) in a type AB (mixed) thymoma Cancer Genet Cytogenet 131 42 7
17. T Kirchner B Schalke J Buchwald M Ritter A Marx HK Muller-Hermelink 1992 Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma Am J Surg Pathol 16 1153 69
18. A Zettl P Strobel K Wagner T Katzenberger G Ott A Rosenwald 2000 Recurrent genetic aberrations in thymoma and thymic carcinoma Am J Pathol 157 257 66
19. B Scheijen M Bronk T van der Meer D De Jong R Bernards 2004 High incidence of thymic epithelial tumors in E2F2 transgenic mice J Biol Chem 279 10476 83
20. Y Fujiwara M Emi H Ohata Y Kato T Nakajima T Mori 1993 Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma Cancer Res 53 1172 4
21. ML Yaremko C Kutza J Lyzak R Mick WM Recant CA Westbrook 1996 Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer Genes Chromosomes Cancer 16 189 95
22. A Latil O Cussenot G Fournier K Driouch R Lidereau 1997 Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions Cancer Res 57 1058 62
23. L Lauriola RA Erlandson J Rosai 1998 Neuroendocrine differentiation is a common feature of thymic carcinoma Am J Surg Pathol 22 1059 66
24. CA Moran S Suster 2000 Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases Am J Clin Pathol 114 100 10
25. K Goto T Kodama Y Matsuno T Yokose H Asamura N Kamiya 2001 Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus Mod Pathol 14 985 94
26. S Suster CA Moran 1996 Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases Am J Surg Pathol 20 1469 80
27. S Suster CA Moran 1999 Micronodular thymoma with lymphoid B-cell hyperplasia: clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm Am J Surg Pathol 23 955 62
28. H Tateyama Y Saito Y Fujii M Okumura K Nakamura H Tada 2001 The spectrum of micronodular thymic epithelial tumours with lymphoid B-cell hyperplasia Histopathology 38 519 27
29. V Thomas De Montpreville L Zemoura E Dulmet 2002 Thymoma with epithelial micronodules and lymphoid hyperplasia: six cases of a rare and equivocal subtype Ann Pathol 22 177 82
30. TW Noh SH Kim BJ Lim WI Yang KY Chung 2001 Thymoma with pseudosarcomatous stroma Yonsei Med J 42 571 75
31. S Suster CA Moran JK Chan 1997 Thymoma with pseudosarcomatous stroma: report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma Am J Surg Pathol 21 1316 23
32. S Yoneda A Marx S Heimann T Shirakusa M Kikuchi HK Muller-Hermelink 1999 Low-grade metaplastic carcinoma of the thymus Histopathology 35 19 30
33. A Franke P Strobel V Fackeldey R Schafer T Goller HP Becker 2004 Hepatoid thymic carcinoma: report of a case Am J Surg Pathol 28 250 6
34. CA Moran S Suster 1997 Hepatoid yolk sac tumors of the mediastinum: a clinicopathologic and immunohistochemical study of four cases Am J Surg Pathol 21 1210 14
35. I Kubonishi N Takehara J Iwata H Sonobe Y Ohtsuki T Abe 1991 Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma Cancer Res 51 3327 8
36. CA French I Miyoshi JC Aster I Kubonishi TG Kroll P Dal Cin 2001 BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19) Am J Pathol 159 1987 92
37. CA French I Miyoshi I Kubonishi HE Grier AR Perez-Atayde JA Fletcher 2003 BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma Cancer Res 63 304 7
38. K Kondo Y Monden 2003 Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan Ann Thorac Surg 76 878 84 discussion 884-75
39. K Ogawa T Toita T Uno N Fuwa Y Kakinohana M Kamata 2002 Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases Cancer 94 3115 9
40. K Koga Y Matsuno M Noguchi K Mukai H Asamura T Goya 1994 A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma Pathol Int 44 359 67
41. K Nakagawa H Asamura Y Matsuno K Suzuki H Kondo A Maeshima 2003 Thymoma: a clinicopathologic study based on the new World Health Organization classification J Thorac Cardiovasc Surg 126 1134 40
42. K Ogawa T Uno T Toita H Onishi H Yoshida Y Kakinohana 2002 Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients Cancer 94 1405 13
43. S Gripp K Hilgers R Wurm G Schmitt 1998 Thymoma: prognostic factors and treatment outcomes Cancer 83 1495 503
44. Y Eralp A Aydiner A Kizir E Kaytan EN Oral E Topuz 2003 Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group Cancer Invest 21 737 43
45. G Maggi C Casadio A Cavallo R Cianci M Molinatti E Ruffini 1991 Thymoma: results of 241 operated cases Ann Thorac Surg 51 152 6
46. R Schmidt SP Monig M Selzner B Krug 1997 Surgical therapy of malignant thymoma J Cardiovasc Surg (Torino) 38 317 22
47. AA Mangi CD Wright JS Allan JC Wain DM Donahue HC Grillo 2002 Adjuvant radiation therapy for stage II thymoma Ann Thorac Surg 74 1033 7
48. S Singhal JB Shrager DI Rosenthal VA LiVolsi LR Kaiser 2003 Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation Ann Thorac Surg 76 1635 41 discussion 1641-32
49. M Myojin NC Choi CD Wright JC Wain N Harris EB Hug 2000 Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study Int J Radiat Oncol Biol Phys 46 927 33
50. M Uematsu H Yoshida M Kondo J Itami K Hatano K Isobe 1996 Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma Int J Radiat Oncol Biol Phys 35 357 60
51. HT Tran Blumenschein GR Jr C Lu CA Meyers V Papadimitrakopoulou FV Fossella 2004 Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors Cancer Chemother Pharmacol 54 308 14
52. F Venuta EA Rendina F Longo T De Giacomo M Anile E Mercadante 2003 Long-term outcome after multimodality treatment for stage III thymic tumors Ann Thorac Surg 76 1866 72
53. S Bretti A Berruti C Loddo P Sperone C Casadio M Tessa 2004 Multimodal management of stages III-IV a malignant thymoma Lung Cancer 44 69 77
54. FC Detterbeck AM Parsons 2004 Thymic tumors Ann Thorac Surg 77 1860 9
55. A Kurup PJ Loehrer Sr 2004 Thymoma and thymic carcinoma: therapeutic approaches Clin Lung Cancer 6 28 32
56. G Palmieri L Montella A Martignetti P Muto D Di Vizio A De Chiara 2002 Somatostatin analogs and prednisone in advanced refractory thymic tumors Cancer 94 1414 20
57. Grimberg A. Somatostatin and cancer: applying endocrinology to oncology. Cancer Biol Ther 2004;3
58. Loehrer PJ Sr W Wang DH Johnson SC Aisner DS Ettinger 2004 Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial J Clin Oncol 22 293 9
59. J Anido P Matar J Albanell M Guzman F Rojo J Arribas 2003 ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells Clin Cancer Res 9 1274 83
60. JD Henley OW Cummings PJ Loehrer Sr 2004 Tyrosine kinase receptor expression in thymomas J Cancer Res Clin Oncol 130 222 4
61. CC Pan PC Chen H Chiang 2004 KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas J Pathol 202 375 81
62. P Strobel M Hartmann A Jakob K Mikesch I Brink S Dirnhofer 2004 Thymic carcinoma with overexpression of mutated KIT and the response to imatinib N Engl J Med 350 2625 6
63. BJ Longley MJ Reguera Y Ma 2001 Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy Leukemia Res 25 571 6
64. ML Privalsky R Ralston JM Bishop 1984 The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases Proc Natl Acad Sci USA 81 704 7
65. J Schlessinger 2000 Cell signaling by receptor tyrosine kinases Cell 103 211 25
66. FR Hirsch M Varella-Garcia PA Bunn Jr MV Di Maria R Veve RM Bremmes 2003 Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 3798 807
67. DK Moscatello M Holgado-Madruga AK Godwin G Ramirez G Gunn PW Zoltick 1995 Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors Cancer Res 55 5536 9
68. N Prenzel E Zwick H Daub M Leserer R Abraham C Wallasch 1999 EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 884 8
69. D Liu J Aguirre Ghiso Y Estrada L Ossowski 2002 EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma Cancer Cell 1 445 57
70. NE Gilhus M Jones H Turley KC Gatter N Nagvekar J Newsom-Davis 1995 Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen J Clin Pathol 48 447 55
71. Y Hayashi N Ishii C Obayashi K Jinnai K Hanioka Y Imai 1995 Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21 Virchows Arch 426 43 50
72. E Pescarmona A Pisacane E Pignatelli CD Baroni 1993 Expression of epidermal and nerve growth factor receptors in human thymus and thymomas Histopathology 23 39 44
73. HS Parra R Cavina F Latteri PA Zucali E Campagnoli E Morenghi 2004 Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ("Iressa", ZD1839) in non-small-cell lung cancer Br J Cancer 91 208 12
74. LB Saltz NJ Meropol Loehrer PJ Sr MN Needle J Kopit RJ Mayer 2004 Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor J Clin Oncol 22 1201 8
75. P Krawczyk S Chocholska J Milanowski 2003 Anti-HER therapeutic agents in the treatment of non-small-cell lung cancer Ann Univ Mariae Curie Sklodowska [Med] 58 113 7
76. Y Hinoda S Sasaki T Ishida K Imai 2004 Monoclonal antibodies as effective therapeutic agents for solid tumors Cancer Sci 95 621 5
77. JD Patel B Pasche A Argiris 2004 Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go Crit Rev Oncol Hematol 50 175 86
78. F Ciardiello F De Vita M Orditura S De Placido G Tortora 2003 Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials Expert Opin Emerg Drugs 8 501 14
79. BF El-Rayes PM LoRusso 2004 Targeting the epidermal growth factor receptor Br J Cancer 91 418 24